Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xinwei Daniel Jia
Observed names:
Xinwei D Jia,
Xinwei D. Jia,
Xinwei Jia
Observed institutions:
Janssen (Belgium),
Allergan (United States),
Sandoz Group AG (Switzerland),
Forest Laboratories (United States),
Indiana University – Purdue University Indianapolis
OpenAlex ID:
A5110045908
Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety
2012
·
William D Chey
, Anthony J Lembo
, et al.
·
The American Journal of Gastroenterology
·
463
A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation
2012
·
Satish Rao
, Anthony J Lembo
, et al.
·
The American Journal of Gastroenterology
·
383
Two Randomized Trials of Linaclotide for Chronic Constipation
2011
·
Anthony J. Lembo
, Harvey A. Schneier
, et al.
·
New England Journal of Medicine
·
373
PDF
A Randomized, Placebo-Controlled Study of Memantine as Adjunctive Treatment in Patients with Schizophrenia
2008
·
for the MEM-MD-29 Study Group
, Jeffrey A Lieberman
, et al.
·
Neuropsychopharmacology
·
162
Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial
2015
·
Brian E. Lacy
, Ron Schey
, et al.
·
PLoS ONE
·
81
PDF
An extension of satterth waite's approximation applied to pharmacokinetics
1998
·
Jerry R. Nedelman
, Xinwei Jia
·
Journal of Biopharmaceutical Statistics
·
64
Pharmacokinetic and Safety Assessments of Concurrent Administration of Risperidone and Donepezil
2003
·
Qinying Zhao
, Charles Xie
, et al.
·
The Journal of Clinical Pharmacology
·
32
286 Efficacy and Safety of Once Daily Linaclotide Administered Orally for 12-Weeks in Patients With Chronic Constipation: Results From 2 Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials
2010
·
Anthony Lembo
, Harvey Schneier
, et al.
·
Gastroenterology
·
20
P4‐405: A multinational, randomized, double‐blind, placebo‐controlled, parallel‐group trial of memantine extended‐release capsule (28 mg, once daily) in patients with moderate to severe Alzheimer's disease
2008
·
George Grossberg
, Facundo Manes
, et al.
·
Alzheimer s & Dementia
·
10
Extent of load-independence of pressure-normalized stress in swine
2013
·
Xinwei Jia
, Jenny S Choy
, et al.
·
Experimental Biology and Medicine
·
4
Mo1856 Linaclotide Significantly Improved Abdominal Pain Compared With Placebo in Patients With Irritable Bowel Syndrome Regardless of Baseline Pain Severity in Two Phase 3 Trials
2012
·
Philip S. Schoenfeld
, William D. Chey
, et al.
·
Gastroenterology
·
4
PDF
Tu1069 Do Baseline Factors Contribute to Treatment Satisfaction in Patients With Chronic Constipation Treated With Linaclotide vs Placebo?
2012
·
Philip S. Schoenfeld
, Lin Chang
, et al.
·
Gastroenterology
·
4
PDF
Tu1068 Effects of Linaclotide Treatment on Patient-Reported Ratings of Change for Symptoms of Irritable Bowel Syndrome With Constipation (IBS-C): Pooled 12-Week Findings From Two Phase 3 Trials
2012
·
Giles R. Locke
, William D. Chey
, et al.
·
Gastroenterology
·
4
The Effect of Linaclotide on Measures of Abdominal and Bowel Symptoms in Patients With Chronic Constipation and Abdominal Pain: Pooled Results From Two Phase 3 Trials
2011
·
Anthony Lembo
, Harvey Schneier
, et al.
·
Gastroenterology
·
3
PDF
Errors in time in pharmacokinetic studies
1996
·
Xinwei Jia
, Jerry R. Neldelman
·
Journal of Biopharmaceutical Statistics
·
3
Mo2054 Assessing Abdominal and Bowel Symptoms Using Adequate Relief Based Thresholds: Results From 2 Phase 3 Trials of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation
2013
·
Michael Camilleri
, Anthony Lembo
, et al.
·
Gastroenterology
·
2
PDF
Sa1094 Developing Benchmarks for Clinically Meaningful Change for IBS-C Symptoms Using Data From Two Phase 3 Trials of Linaclotide
2012
·
Brennan M. Spiegel
, Giles R. Locke
, et al.
·
Gastroenterology
·
2
Efficacy and Safety of Once-daily Linaclotide Administered Orally for 12-Weeks in Patients with Chronic Constipation: Pooled Results from 2 Randomized, Double-blind, Placebo-controlled Phase 3 Trials
2010
·
Anthony Lembo
, Harvey Schneier
, et al.
·
The American Journal of Gastroenterology
·
2
Sa2008 Efficacy and Safety of Linaclotide in Chronic Idiopathic Constipation Patients With Abdominal Bloating: Phase 3b Trial Results
2014
·
Brian E. Lacy
, Anthony Lembo
, et al.
·
Gastroenterology
·
1
On weak consistency in linear models with equi-correlated random errors
2003
·
Xinwei Jia
, M. Bhaskara Rao
, et al.
·
Statistics
·
1
PDF
Correlation of Global Assessments with Symptom Endpoints in Phase 3 Clinical Trials of Linaclotide in Chronic Constipation
2010
·
Anthony Lembo
, Harvey Schneier
, et al.
·
The American Journal of Gastroenterology
Show more works
View as search
Works count:
22
Citation count:
1,618
H-index:
9
I10-index:
9
Year
Topic
Type